A study to evaluate the efficacy of Aragwadha Pushpa Lepa in the management of Vyanga with special reference to Melasma

A randomized controlled clinical study to evaluate the efficacy of Aragwadha Pushpa Lepa (Cassia fistula Linn.) in the management of Vyanga with special reference to Melasma

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/07/043645

Enrollment

Registered

2022-07-01

Start date

Unknown

Completion date

Unknown

Last updated

2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects fulfilling the diagnostic criteria of Vyanga with special reference to Melasma will be randomly selected, irrespective of their religion, occupation and socio-economic status

Exclusion criteria

Exclusion criteria: 1) Female on oral contraceptive pills, pregnant women and lactating women 2) Who are on any hormonal therapy 3) Known hyperpigmentation since birth 4) Known inflammatory pigmentation 5) Known malignant melanoma 6) Any other condition interfering with the course of the treatment

Design outcomes

Primary

Measure	Time frame
Improved uniformity in colour of facial skinTimepoint: 30 days	—

Secondary

Measure	Time frame
Reduction in number of hyper pigmented lesions over facial skinTimepoint: 30 days	—

Countries

India

Contacts

Public ContactDr Nanditha M

Sri Sri College of Ayurvedic Science and Research

drmaheshcd@yahoo.co.in8073119372

Outcome results